Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Meeting Report
  • Published:

Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd–25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies

Bone Marrow Transplantation volume 38, pages 593–607 (2006)Cite this article

Abstract

The Seventh International Symposium on graft-versus-host and graft-versus-leukemia reactions was held in Garmisch Partenkirchen (Germany, near Lake Riessersee) between January 22nd and 25th, 2006. A total of more than 100 invited participants (scientists and clinicians working in the area of allogeneic stem cell transplantation) discussed research in the area of lymphoid malignancies. Major topics of the 2006 meeting were lymphocyte biology, experimental systems, lymphoma pathogenesis, cellular therapy in vivo and vitro, idiotype-specific responses and graft-versus-malignancy reactions for lymphomas and multiple myeloma. Further highlights were immune responses to blasts of ALL, haploidentical transplantation, role of natural killer cells, clinical guidelines for allogeneic transplantation and adoptive immunotherapy in chronic lymphocytic leukemia and multiple myeloma, new antibody-mediated strategies. As can be seen in the summaries of the individual presentations, progress was made in the understanding of lymphoma biology and in the clinical application of graft-versus-lymphoma or graft-versus-myeloma effects. Each day was followed by round-table discussions, which summarized new data and challenged established concepts. The discussions resulted in new insights and projects for basic research and clinical transplantation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Boehm T, Hofer S, Winklehner P, Kellersch B, Geiger C, Trockenbacher A et al. Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration. EMBO J 2003; 22: 1014–1024.

    Article  CAS  Google Scholar 

  2. Hofer S, Pfeil K, Niederegger H, Ebner S, Nguyen VA, Kremmer E et al. Dendritic cells regulate T-cell deattachment through the integrin-interacting protein CYTIP. Blood 2006; 107: 1003–1009.

    Article  CAS  Google Scholar 

  3. Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu D . DNA fusion gene vaccines against cancer: from the laboratory to the clinic. Immunol Rev 2004; 199: 156–180.

    Article  CAS  Google Scholar 

  4. Rice J, Buchan S, Dewchand H, Simpson E, Stevenson FK . DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire. J Immunol 2004; 173: 4492–4499.

    Article  CAS  Google Scholar 

  5. Buchan S, Gronevik E, Mathiesen I, King CA, Stevenson FK, Rice J . Electroporation as a ‘Prime/Boost’ strategy for naked DNA vaccination against a tumor antigen. J Immunol 2005; 174: 6292–6298.

    Article  CAS  Google Scholar 

  6. Adler H, Messerle M, Wagner M, Koszinowski UH . Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 2000; 74: 6964–6974.

    Article  CAS  Google Scholar 

  7. Adler H, Messerle M, Koszinowski UH . Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences. J Virol 2001; 75: 5692–5696.

    Article  CAS  Google Scholar 

  8. Adler H, Messerle M, Koszinowski UH . Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev Med Virol 2003; 13: 111–121.

    Article  CAS  Google Scholar 

  9. Küppers R . Mechanisms of B cell lymphoma pathogenesis. Nat Rev Cancer 2005; 5: 251–262.

    Article  Google Scholar 

  10. Bechtel D, Kurth J, Unkel C, Küppers R . Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphoma. Blood 2005; 106: 4345–4350.

    Article  CAS  Google Scholar 

  11. Bräuninger A, Schmitz R, Bechtel D, Renne C, Hansmann ML, Küppers R . Molecular biology of Hodgkin and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer 2006; 118: 1853–1861.

    Article  Google Scholar 

  12. Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A et al. Cytotoxic T lymphocyte therapy for Epstein–Barr virus+ Hodgkin's disease. J Exp Med 2004; 200: 1623–1633.

    Article  CAS  Google Scholar 

  13. Gottschalk S, Heslop H, Rooney C . Adoptive immunotherapy for EBV-associated malignancies. Leuk Lymphoma 2005; 46: 1–10.

    Article  CAS  Google Scholar 

  14. Gribben JG, Zahrieh D, Stephans K, Bartlett-Pandite L, Alyea EP, Fisher DC et al. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Blood 2005; 106: 4389–4396.

    Article  CAS  Google Scholar 

  15. Trojan A, Schultze JL, Witzens M, Vonderheide RH, Ladetto M, Donovan JW et al. Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. Nat Med 2000; 6: 667–672.

    Article  CAS  Google Scholar 

  16. Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF et al. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression. Cancer Res 2006; 66: 4496–4502.

    Article  CAS  Google Scholar 

  17. Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005; 105: 3051–3057.

    Article  CAS  Google Scholar 

  18. Imai C, Iwamoto S, Campana D . Genetic modification of primary natural killer cells overcomes inhibitory cells and induces specific killing of leukemic cells. Blood 2005; 106: 376–383.

    Article  CAS  Google Scholar 

  19. Kröger N, Schwerdtfeger R, Kiehl M, Sayer HG, Renges H, Zabelina T et al. Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma. Blood 2002; 100: 755–760.

    Article  Google Scholar 

  20. Kröger N, Shaw B, Iacobelli S, Zabelina T, Peggs K, Shimoni A et al. Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. Br J Haematol 2005; 129: 631–643.

    Article  Google Scholar 

  21. Kröger N, Shimoni A, Zagrivnaja M, Ayuk F, Lioznov M, Schieder H et al. Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma. Blood 2004; 104: 3361–3363.

    Article  Google Scholar 

  22. Ayuk F, Fang L, Fehse B, Zander AR, Kröger N . Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells. Exp Hematol 2005; 33: 1531–1536.

    Article  CAS  Google Scholar 

  23. Jedema I, Van der Werff NM, Barge RMY, Willemze R, Falkenburg JH . New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 2004; 103: 2677–2682.

    Article  CAS  Google Scholar 

  24. Hoogendoorn M, Olde Wolbers J, Smit WM, Schaafsma MR, Barge RM, Willemze R et al. Generation of B cell chronic lymphocytic leukemia (B-CLL)-reactive T cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy. Leukemia 2004; 18: 1278–1287.

    Article  CAS  Google Scholar 

  25. Hoogendoorn M, Olde Wolbers J, Smit WM, Jedema I, Barge RM, Willemze R et al. Primary allogeneic T cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation. Clin Cancer Res 2005; 15: 5310–5318.

    Article  Google Scholar 

  26. Leung W, Iyengar R, Turner V, Lang P, Bader P, Conn P et al. Determinants of antileukemic effects of allogeneic NK cells. J Immunol 2004; 172: 644–650.

    Article  CAS  Google Scholar 

  27. Lang P, Barbin K, Feuchtinger T, Greil J, Peipp M, Zunino SJ et al. Chimeric CD19 antibody mediates cytotoxic activity against leukemic blast with effector cells from pediatric patients who received T-cell-depleted allografts. Blood 2004; 103: 3982–3985.

    Article  CAS  Google Scholar 

  28. Leung W, Iyengar R, Triplett B, Turner V, Behm FG et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immun 2005; 174: 6540–6545.

    Article  CAS  Google Scholar 

  29. Kolb HJ, Schmid C, Barrett AJ, Schendel DJ . Graft-versus-leukemia reactions in allogeneic chimeras. Blood 2004; 103: 767–776.

    Article  CAS  Google Scholar 

  30. Munker R, Schmid C, Madrigal JA, Kolb HJ . An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth international symposium held in Schloss Ellmau, Germany 22–24, 2004. Bone Marrow Transplant 2004; 34: 767–780.

    Article  CAS  Google Scholar 

  31. Moreno C, Villamor N, Colomer D, Esteve J, Gine E, Muntanola A et al. Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia. Blood 2006; 107: 4563–4569.

    Article  CAS  Google Scholar 

  32. Michallet M, Archimbaud E, Bandini G, Rowlings PA, Deeg HJ, Gahrton G et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. Ann Int Med 1996; 124: 311–315.

    Article  CAS  Google Scholar 

  33. Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J et al. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. J Clin Oncol 2003; 21: 2747–2753.

    Article  CAS  Google Scholar 

  34. Hallek M . Chemoimmunotherapy – towards real progress in the treatment of chronic lymphocytic leukemia. Nat Clin Pract Oncol 2005; 2: 338–339.

    Article  Google Scholar 

  35. Mayr C, Bund D, Schlee M, Moosmann A, Kofler DM, Hallek M et al. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. Blood 2005; 105: 1566–1573.

    Article  CAS  Google Scholar 

  36. Mayr C, Kofler DM, Buning H, Bund D, Hallek M, Wendtner CM . Transduction of CLL cells by CD40 ligand (CD40L) enhances an antigen specific immune recognition by autologous T cells. Blood 2005; 106: 3223–3226.

    Article  CAS  Google Scholar 

  37. Lux K, Goerlitz N, Schlemminger S, Perabo L, Goldnau D, Endell J et al. GFP-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking. J Virol 2005; 79: 11776–11787.

    Article  CAS  Google Scholar 

  38. Seisenberger G, Ried MU, Endress T, Buning H, Hallek M et al. Real-time single molecule imaging of the infection pathway of an adeno-associated virus. Science 2001; 294: 1929–1932.

    Article  CAS  Google Scholar 

  39. Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J et al. Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2 (AAV2). Nat Med 1999; 5: 1052–1056.

    Article  CAS  Google Scholar 

  40. Morecki S, Lindhofer H, Yacovlev E, Gelfand Y, Slavin S . Use of trifunctional bispecific antibodies to prevent graft-versus host disease induced by allogeneic lymphocytes. Blood 2006; 107: 1564–1569.

    Article  CAS  Google Scholar 

  41. Arditti FD, Aviner S, Dekel B, Krautgamer R, Gan J, Nagler A et al. Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third party CTLs. Blood 2005; 105: 3365–3371.

    Article  CAS  Google Scholar 

  42. Pedersen AE, Skov S, Bregenholt S, Ruhwald M, Claesson MH . Signal transduction by the major histocompatibility class I molecule. APMIS 1999; 107: 887–895.

    Article  CAS  Google Scholar 

  43. Collin MP, Hart DN, Jackson GH, Cook G, Cavet J, Mackinnon S et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med 2006; 203: 27–33.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This year's symposium (‘Tolerance and Immunity’) was jointly organized by the Ludwigs-Maximilians-University of Munich (Sonderforschungsbereich 455), GSF (National Research Center for Environment and Health), Stiftung Aktion Knochenmarkspende Bayern and supported by Deutsche José Carreras Leukämie Stiftung. The organizers and authors of the conference proceedings would again like to extend their gratitude to all participants for sharing their ideas, slides and manuscripts and making this event possible.

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Louisiana State University Health Sciences Center, Shreveport, LA, USA

    R Munker

  2. Medizinische Klinik III der Ludwig-Maximilians-Universität (Klinikum Grosshadern), Munich, Germany

    R Reibke & H J Kolb

  3. GSF Clinical Cooperative Group for Hematopoietic Cell Transplantation, Munich, Germany

    H J Kolb

Authors
  1. R Munker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Reibke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H J Kolb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Munker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Munker, R., Reibke, R. & Kolb, H. Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd–25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies. Bone Marrow Transplant 38, 593–607 (2006). https://doi.org/10.1038/sj.bmt.1705499

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705499

Keywords

This article is cited by

Search

Advanced search

Quick links